NCT03347877

Brief Summary

The trial evaluates the clinical efficacy and safety of autologous osteo-periosteal cylinder graft transplantation for Hepple V osteochondral lesions of the talus. Half of participants will receive autologous osteo-periosteal cylinder graft transplantation, while the other will receive osteochondral graft transplantation as a control group.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jan 2018Dec 2026

First Submitted

Initial submission to the registry

November 15, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 20, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

August 27, 2025

Status Verified

June 1, 2025

Enrollment Period

9 years

First QC Date

November 15, 2017

Last Update Submit

August 20, 2025

Conditions

Keywords

autologous osteo-periosteal cylinder graftautologous osteochondral graftrandomized controlled trialHepple V osteochondral lesions of the talus

Outcome Measures

Primary Outcomes (1)

  • American Orthopaedic Foot & Ankle Society(AOFAS) ankle-hindfoot score

    American Orthopaedic Foot \& Ankle Society(AOFAS) ankle-hindfoot score. The higher score represent the better outcome.

    4 years

Secondary Outcomes (4)

  • International Cartilage Repair Society(ICRS) score

    4 years

  • Magnetic Resonance Observation of cartilage repair tissue(MOCART) score

    4 years

  • Tegner activity level score

    4 years

  • Visual analogue scale

    4 years

Study Arms (2)

autologous bone-periosteal graft

EXPERIMENTAL

The patients in experimental group will undergo the surgery of arthroscopic repair Hepple V osteochondral lesions of the talus with autologous osteo-periosteal cylinder graft transplantation.

Procedure: autologous osteo-periosteal cylinder graft transplantationDevice: autologous osteo-periosteal cylinder graft

autologous osteochondral graft

ACTIVE COMPARATOR

The patients in control group will undergo the surgery of arthroscopic repair Hepple V osteochondral lesions of the talus with autologous osteochondral graft transplantation.

Procedure: autologous osteochondral graft transplantation

Interventions

Autologous osteo-periosteal cylinder graft transplantation is a novel treatment for Hepple V osteochondral lesions of the talus.

autologous bone-periosteal graft

Autologous osteochondral graft transplantation is the most common treatment for Hepple V osteochondral lesions of the talus.

autologous osteochondral graft

Autologous osteo-periosteal cylinder graft is taken from ilium.

autologous bone-periosteal graft

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old, male or female
  • Chronic pain in the ankle, confirmed by ankle joint MRI as Hepple V osteo-chondral lesions of the talus
  • Using rest/external use/oral non-steroidal anti-inflammatory drugs and other conservative treatment for more than 3 months ineffective
  • Patients voluntarily participated in clinical trials, signed informed consent, with clinical follow-up

You may not qualify if:

  • In the last 6 months patients participated in other drug or medical device clinical trials
  • Line of force in ankle is not correct (varus or valgus\> 5 degrees)
  • Grade III ankle collateral ligament injury
  • Chronic specific synovitis (rheumatoid, pigmented villonodular synovitis, etc.)
  • Joint fibrosis, ankylosis, activity was significantly limited
  • Moderate and severe osteoarthritis
  • There are MRI contraindications
  • Hemophilia patients
  • The general condition of patients can not tolerate surgery
  • Pregnant or planned pregnant women and lactating women
  • Abnormal mental capacity without autonomy
  • Other conditions in which the doctor can not decide to participate in the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Medicine

Beijing, Beijing Municipality, 100000, China

Location

Related Publications (2)

  • Yang S, Hu F, Shao Q, Zhang Z, Liu X, Jiang Y, Jiang D, Xie X, Jiao C, Hu Y, Shi W, Guo Q. Autologous Osteoperiosteal Transplantation Versus Autologous Osteochondral Transplantation for Large Cystic Osteochondral Lesions of the Medial Talus: 2-Year Results From a Prospective Randomized Controlled Trial. Am J Sports Med. 2025 Sep;53(11):2642-2651. doi: 10.1177/03635465251361505. Epub 2025 Aug 19.

  • Deng E, Shi W, Jiang Y, Guo Q. Comparison of autologous osteoperiosteal cylinder and osteochondral graft transplantation in the treatment of large cystic osteochondral lesions of the talus (OLTs): a protocol for a non-inferiority randomised controlled trial. BMJ Open. 2020 Feb 9;10(2):e033850. doi: 10.1136/bmjopen-2019-033850.

Study Officials

  • Qinwei Guo

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Associate Professor and Chief Orthopedist of Orthopedic Sports Medicine

Study Record Dates

First Submitted

November 15, 2017

First Posted

November 20, 2017

Study Start

January 1, 2018

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

August 27, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations